CME Group (NASDAQ:CME – Get Free Report) issued its quarterly earnings data on Wednesday. The financial services provider reported $2.99 earnings per share for the quarter, topping analysts’ consensus estimates of $2.91 by $0.08, FiscalAI reports. CME Group had a return on equity of 15.42% and a net margin of 63.19%.The firm had revenue of $1.71 billion during the quarter, compared to analysts’ expectations of $1.68 billion.
CME Group Price Performance
Shares of NASDAQ CME opened at $237.41 on Wednesday. CME Group has a fifty-two week low of $218.31 and a fifty-two week high of $329.16. The company has a market cap of $86.03 billion, a PE ratio of 20.26, a P/E/G ratio of 3.05 and a beta of 0.25. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02. The business has a 50-day simple moving average of $256.83 and a two-hundred day simple moving average of $281.68.
CME Group Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Thursday, June 25th. Shareholders of record on Tuesday, June 9th were issued a $1.30 dividend. This represents a $5.20 annualized dividend and a yield of 2.2%. The ex-dividend date of this dividend was Tuesday, June 9th. CME Group’s dividend payout ratio (DPR) is currently 44.37%.
CME Group News Summary
- Positive Sentiment: CME Group beat Q2 earnings and revenue estimates, showing continued strength in trading volume and core exchange activity. CME Group Inc. Reports Strong Financial Results for Q2 2026
- Positive Sentiment: The company highlighted strong operating performance, with second-quarter operating income of about $1.1 billion and continued high market participation. CME Group Q2 earnings beat, buoyed by second-highest trading volume
- Neutral Sentiment: Analyst coverage remains mixed, with recent price targets ranging from the mid-$200s to the low-$300s, suggesting expectations are still divided on how much upside remains. CME: Q2 Earnings Snapshot
- Negative Sentiment: The stock is still trading well below its recent moving averages, indicating investors remain cautious despite the earnings beat.
Insider Activity
In related news, insider Hilda Harris Piell sold 5,753 shares of CME Group stock in a transaction that occurred on Monday, May 18th. The shares were sold at an average price of $304.63, for a total value of $1,752,536.39. Following the completion of the sale, the insider directly owned 27,702 shares in the company, valued at $8,438,860.26. This trade represents a 17.20% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO Terrence A. Duffy sold 35,000 shares of the business’s stock in a transaction that occurred on Friday, May 15th. The stock was sold at an average price of $298.51, for a total transaction of $10,447,850.00. Following the sale, the chief executive officer directly owned 55,630 shares in the company, valued at approximately $16,606,111.30. This represents a 38.62% decrease in their position. The SEC filing for this sale provides additional information. Corporate insiders own 0.30% of the company’s stock.
Institutional Investors Weigh In On CME Group
Several institutional investors and hedge funds have recently made changes to their positions in CME. Empowered Funds LLC grew its holdings in shares of CME Group by 11.5% during the first quarter. Empowered Funds LLC now owns 10,027 shares of the financial services provider’s stock valued at $2,660,000 after buying an additional 1,037 shares during the last quarter. Marshall Wace LLP raised its stake in CME Group by 103.1% in the 2nd quarter. Marshall Wace LLP now owns 3,692 shares of the financial services provider’s stock worth $1,018,000 after acquiring an additional 121,707 shares during the last quarter. Federated Hermes Inc. lifted its position in CME Group by 1,325.2% during the 2nd quarter. Federated Hermes Inc. now owns 23,572 shares of the financial services provider’s stock worth $6,497,000 after acquiring an additional 21,918 shares during the period. Nebula Research & Development LLC acquired a new stake in CME Group during the 2nd quarter worth about $992,000. Finally, The Manufacturers Life Insurance Company grew its stake in CME Group by 2.6% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 287,876 shares of the financial services provider’s stock valued at $79,344,000 after purchasing an additional 7,397 shares during the last quarter. 87.75% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
A number of equities analysts have commented on the stock. Jefferies Financial Group reduced their target price on shares of CME Group from $356.00 to $349.00 and set a “buy” rating for the company in a report on Thursday, April 9th. Rothschild & Co Redburn raised shares of CME Group from a “neutral” rating to a “buy” rating and lifted their price objective for the stock from $316.00 to $323.00 in a research report on Thursday, June 11th. JPMorgan Chase & Co. boosted their price objective on shares of CME Group from $266.00 to $271.00 and gave the stock an “underweight” rating in a research note on Thursday, April 16th. Piper Sandler decreased their target price on shares of CME Group from $329.00 to $295.00 and set an “overweight” rating for the company in a research report on Wednesday, July 15th. Finally, Deutsche Bank Aktiengesellschaft decreased their target price on shares of CME Group from $342.00 to $322.00 and set a “buy” rating for the company in a research report on Thursday, April 23rd. Twelve investment analysts have rated the stock with a Buy rating, four have given a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat.com, CME Group presently has an average rating of “Moderate Buy” and an average target price of $292.12.
Get Our Latest Stock Analysis on CME Group
CME Group Company Profile
CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.
The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.
Read More
- Five stocks we like better than CME Group
- Has Wall Street Got Monday.com Completely Wrong?
- Archer and Anduril Put ACHR Stock on a New Defense Flight Path
- PayPal Rejected a $53 Billion Takeover Bid: Is the Stock Undervalued?
- Confidence Is Back, But Earnings Show the Consumer Is Being Picky
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.
